Plus Therapeutics to Participate in Upcoming November Investor Conferences

On November 16, 2020 Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage company focused on making a positive impact on patients’ lives, reported that Company management has been invited to participate in two upcoming virtual investor conferences (Press release, PLUS THERAPEUTICS, NOV 16, 2020, View Source [SID1234572300]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event Virtual Fall Investor Summit
Date November 17, 2020
Presentation Time 3:00 p.m. ET

Event A.G.P. Virtual Healthcare Symposium
Date November 19, 2020
Investors interested in arranging a virtual 1×1 meeting with Company management during these conferences should contact the respective conference coordinator.

A live webcast and subsequent archived recording of the Company’s presentation during the Virtual Fall Investor Summit will be available under the ‘Events’ tab of the Investor Relations section of the Plus Therapeutics website at www.plustherapeutics.com.